Spineguard Aktie [WKN DE: A1T9RS / ISIN: FR0011464452]

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (groß)	News + Adhoc	Bilanz/GuV	Termine	Zertifikate	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Optionsscheine	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV	Knock-Outs
Historisch	Analysen

Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch

News + Analysen
News + Adhoc
Analysen
Kursziele

Fundamental
Bilanz/GuV
Schätzungen
Dividende/GV
Analysen

Unternehmen
Termine
Profil

zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs

Nachrichten zu Spineguard

09.07.15		SpineGuard Reports 41% Growth and €3M Revenue for the Half-Year 2015 (Businesswire)
30.06.15		SpineGuard Obtains Regulatory Clearance to Sell PediGuard® in the World’s Second-Largest Spine Market: China (Businesswire)
30.06.15		SpineGuard Obtains Regulatory Clearance to Sell PediGuard® in the World’s Second-Largest Spine Market: China (Businesswire)
15.06.15		SpineGuard Raises €2.8 ($3.1) Million of Fresh Equity Finance (Businesswire)
04.06.15		SpineGuard Closes €1.6 Million Private Placement and Launches €1.8 Million Public Offering Partially Eligible for French TEPA Act Provisions (Businesswire)
04.06.15		SpineGuard Closes €1.6 Million Private Placement and Launches €1.8 Million Public Offering Partially Eligible for French TEPA Act Provisions (Businesswire)
15.04.15		SpineGuard Announces Adoption of its DSG® Technology by the 15th French-Based Spine-Teaching Institution (Businesswire)
15.04.15		SpineGuard Announces Adoption of Its DSG® Technology by the 15th French-Based Spine-Teaching Institution (Businesswire)
08.04.15		SpineGuard Reports €1.5M Revenue and 47% Growth for 1Q15 (Businesswire)
08.04.15		SpineGuard reports €1.5M revenue and 47% growth for 1Q15 (Businesswire)
25.03.15		SpineGuard reports full-year 2014 financial results and provides guidance for 1Q15 revenue (Businesswire)
25.03.15		SpineGuard Reports Full-Year 2014 Financial Results and Provides Guidance for 1Q15 Revenue (Businesswire)
04.03.15		SpineGuard and Zavation Announce the First US Co-Development Partnership for the "Smart Screw” (Businesswire)
04.03.15		SpineGuard and Zavation Announce the First US Co-Development Partnership for the "Smart Screw” (Businesswire)
11.02.15		SpineGuard and Neuro France Implants in Co-Development Partnership for the First "Smart Screw” Based on Dynamic Surgical Guidance (Businesswire)
11.02.15		SpineGuard and Neuro France Implants in Co-Development Partnership for the First "Smart Screw” Based on Dynamic Surgical Guidance (Businesswire)
03.02.15		SpineGuard Receives FDA Clearance to Market Its PediGuard Products for Minimally Invasive Surgery (MIS) (Businesswire)
03.02.15		SpineGuard Receives FDA Clearance to Market Its PediGuard Products for Minimally Invasive Surgery (MIS) (Businesswire)
29.01.15		SpineGuard Receives E.U. Patent for Its "Smart Screw” (Businesswire)
29.01.15		SpineGuard Receives E.U. Patent for its "Smart Screw” (Businesswire)
22.01.15		SpineGuard Reports 2014 Revenue at €4.4M (Businesswire)
22.01.15		SpineGuard Reports 2014 Revenue at €4.4M (Businesswire)
05.01.15		SpineGuard Announces Its 2015 Financial Calendar (Businesswire)
05.01.15		SpineGuard Announces Its 2015 Financial Calendar (Businesswire)
01.12.14		SpineGuard Successfully Passes ANVISA’s Inspection, Paving the Way for Registration of Its New Products in Brazil (Businesswire)
24.09.14		SpineGuard Releases Six Months 2014 Financial Results (Businesswire)
24.09.14		SpineGuard : Six Months 2014 Financial Results (Businesswire)
17.07.14		SpineGuard Reports 1H 2014 Revenues €2.1 Million (Businesswire)
19.06.14		PediGuard® Device From SpineGuard is Recognized as "The Cutting-Edge and the New Gold Standard in Spine Care” by Becker’s Healthcare (Businesswire)
19.06.14		PediGuard® device from SpineGuard is recognized as "the cutting-edge and the new gold standard in spine care” by Becker’s Healthcare (Businesswire)
11.06.14		SpineGuard® Introduces Bevel-Cannulated PediGuard®, the Newest Addition of Its Dynamic Surgical Guidance Platform (Businesswire)
11.06.14		SpineGuard® Introduces Bevel-Cannulated PediGuard®, the Newest Addition of Its Dynamic Surgical Guidance Platform (Businesswire)
27.05.14		SpineGuard Appoints Kris Kumar as U.S. Marketing Director (Businesswire)
27.05.14		SpineGuard Appoints Kris Kumar as U.S. Marketing Director (Businesswire)
13.05.14		Spineguard’s Pediguard® Bone-Monitoring Device is Adopted by 20th U.S. Spine-Surgery Teaching Institution (Businesswire)
29.04.14		PediGuard® Bone-Monitoring Device from SpineGuard Demonstrates High Accuracy for C2-Screw Fixation in Treating 50 Patients with Cervical Spine Disease (Businesswire)
29.04.14		PediGuard® Bone-Monitoring Device from SpineGuard Demonstrates High Accuracy for C2-Screw Fixation in Treating 50 Patients with Cervical Spine Disease (Businesswire)
25.03.14		SpineGuard Reports Full-Year 2013 Financial Results (Businesswire)
27.01.14		SpineGuard Establishes Three-Year, No-Minimum-Draw Standby Equity Facility (PACEO®) with Société Générale (Businesswire)
27.01.14		SpineGuard Establishes Three-Year, No-Minimum-Draw Standby Equity Facility (PACEO®) with Société Générale (Businesswire)
23.01.14		SpineGuard’s 2013 revenue grows 20% to €4.6 million in line with expectations (Businesswire)
02.01.14		SpineGuard Names Pierre Guyot to Board of Directors (Businesswire)
16.12.13		SpineGuard Announces 2014 Dates for Publishing Financial Results (Businesswire)
16.12.13		SpineGuard Announces 2014 Dates for Publishing Financial Results (Businesswire)
19.11.13		SpineGuard Reports Early Adoption of Its PediGuard® Platform by KOL Spine Surgeons at a Leading University School of Medicine in Japan (Businesswire)
28.10.13		SpineGuard Obtains Regulatory Clearance to Sell Pediguard® Curved and Curved XS in Mexico (Businesswire)
28.10.13		SpineGuard Obtains Regulatory Clearance to Sell PediGuard® Curved and Curved XS in Mexico (Businesswire)
17.10.13		SpineGuard: Six-Month 2013 Financial Results (Businesswire)
17.10.13		SpineGuard Reports Six-Month 2013 Financial Results (Businesswire)
07.10.13		Spineguard to Launch Two New Products from Its PediGuard® Platform at North American Spine Society (NASS) Annual Meeting (Businesswire)

Zurück | 1 | 2 | Weiter

Newssuche

Meistgelesene Nachrichten

Bitcoin Kurs Prognose: Absturz auf 90.000 US-Dollar bereits diese Woche?

BYD-Aktie: CEO sieht Chinas Elektroautos als führend in der globalen Konkurrenz

Just Eat-Aktie steigt über 50%: Einigung mit Prosus auf Übernahme für Milliardenbetrag - Prosus-Aktie in Rot

Alibaba-Aktie gibt deutlich ab: Alibaba will Milliarden in Cloud und KI investieren

Apple-Aktie, Google-Aktie, NVIDIA-Aktie uneins: KI-Investitionspläne und mögliche EU-Kartellklage sorgen für Aktienbewegungen

Nach Wahl in Deutschland: Wall Street schließlich uneins -- ATX schließt im Plus -- DAX beendet Handel stärker -- Asiens Börsen letztlich leichter

finanzen.net Apps

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.

JETZT MEHR ERFAHREN

Aktien ATX DAX EuroStoxx 50 Dow Jones NASDAQ 100 Nikkei 225 S&P 500

Kontakt - Impressum - Werbung

Sitemap - Datenschutz - Disclaimer - AGB - Privatsphäre-Einstellungen

Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Financial Information Deutschland GmbH. Verzögerung 15 Min. (Nasdaq, NYSE: 20 Min.).
© 1999-2025 finanzen.net GmbH

*Werbehinweise: Die Billigung des Basisprospekts durch die Bundesanstalt für Finanzdienstleistungsaufsicht ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.

⁵Hinweis zu Plus500: 82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren. Plus500UK Ltd ist zugelassen und reguliert durch Financial Conduct Authority (FRN 509909). Plus500CY Ltd authorized & regulated by CySEC (#250/14).

Währungsrechner News Devisen Dollarkurs Aktienkurse Bitcoin Rohstoffe Fonds

Portfolioname: Watchlistname:
Portfolio:
Name:
Typ:
ISIN:
Börse:
Anzahl:
Aktueller Kurs:
Kurszeit:
Kaufpreis:
Kaufdatum:	26.02.2025 13:46
Kaufwert:	EUR
	Hinzufügen Speichern